69310-55-0 Usage
Uses
Used in Pharmaceutical Industry:
Phosphonic acid, ethynylis utilized as a building block in organic synthesis, particularly for the development of pharmaceuticals. Its ability to form stable complexes with metal ions contributes to the creation of new drug compounds with potential therapeutic applications.
Used in Agrochemical Industry:
Similarly, in the agrochemical sector, Phosphonic acid, ethynylserves as a key component in the synthesis of various agrochemicals. Its metal ion bonding properties can enhance the effectiveness and stability of these products, supporting agricultural productivity.
Used in Coordination Chemistry:
Phosphonic acid, ethynylis employed as a ligand in coordination chemistry. It forms stable complexes with metal ions, which is valuable in research and development for creating new materials with specific properties and applications in various fields.
Used in Industrial Applications:
Due to its strong metal ion bonding ability, Phosphonic acid, ethynylis also used in a variety of industrial applications. This can include areas such as catalysis, where it can improve the efficiency of chemical reactions, or material science, where it can contribute to the development of new composites and coatings.
Check Digit Verification of cas no
The CAS Registry Mumber 69310-55-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,3,1 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 69310-55:
(7*6)+(6*9)+(5*3)+(4*1)+(3*0)+(2*5)+(1*5)=130
130 % 10 = 0
So 69310-55-0 is a valid CAS Registry Number.
69310-55-0Relevant academic research and scientific papers
Triazole phosphohistidine analogues compatible with the Fmoc-strategy
Mcallister, Tom E.,Webb, Michael E.
scheme or table, p. 4043 - 4049 (2012/06/15)
Phosphorylation of histidine is essential for bacterial two-component signalling; its importance to modulation of eukaryotic protein function remains undefined. Until recently, no immunochemical probes of this post-translational modification existed, however triazole phosphonate analogues of this modified amino acid have now been applied to the generation of site-specific antibodies. The protecting group strategy used in the original report is incompatible with standard protocols for Fmoc-solid phase peptide synthesis. In this paper, we report the application of P(iii) chemistry to generate the complementary dibenzyl and di-tert-butyl phosphonate esters. These forms of the triazole analogue are fully compatible with standard Fmoc-SPPS and are therefore ideal for wider application by the chemical and biochemical community.
